Mersana Therapeutics (MRSN)
(Delayed Data from NSDQ)
$2.16 USD
-0.03 (-1.37%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $2.16 0.00 (0.00%) 6:40 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Brokerage Reports
Mersana Therapeutics, Inc. [MRSN]
Reports for Purchase
Showing records 41 - 60 ( 202 total )
Company: Mersana Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Mersana Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Mersana Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Mersana Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Mersana Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Mersana Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
XMT-2056 Granted Orphan Drug Designation by FDA
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Mersana Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
1Q22 Results; UPGRADE Interim Combo Data Expected 4Q22; Discontinuing XMT-1592
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Mersana Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Mersana Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Mersana Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Safety Data Update for UpRi in Ovarian Cancer Expansion Cohort
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Mersana Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Additional Data at SGO UPGRADEs Our Expectations for UpRi
Provider: WEDBUSH SECURITIES INC.
Analyst: Research Department
Company: Mersana Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Mersana Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Mersana Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Mersana Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Riding High on UpRi With All Platforms Engaged
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Mersana Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Mersana Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Mersana Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Mersana Dolin? Out Dolasynthen ADCs to Janssen
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Mersana Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Priorities and Milestones for 2022 Outlined
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department